The chronic rhinosinusitis with nasal polyp patient journey in the United States and Europe.

Chronic Rhinosinusitis Nasal polyps Quality of life Smell

Journal

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313

Informations de publication

Date de publication:
26 Feb 2024
Historique:
received: 13 07 2023
accepted: 12 02 2024
medline: 27 2 2024
pubmed: 27 2 2024
entrez: 26 2 2024
Statut: epublish

Résumé

In this letter to the editor, we present questionnaire-based data assessing the patient journey of adults with moderate-severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the USA and five European countries. These data highlight how long and difficult the patient journey with CRSwNP can be and how improved disease awareness among physicians could lead to more timely diagnosis and treatment, and hence improved management of patients.

Identifiants

pubmed: 38409099
doi: 10.1186/s13223-024-00879-7
pii: 10.1186/s13223-024-00879-7
doi:

Types de publication

Letter

Langues

eng

Pagination

17

Subventions

Organisme : GSK
ID : Study Numbers: 208086 and 213369

Informations de copyright

© 2024. The Author(s).

Références

Bachert C, Marple B, Schlosser RJ, Hopkins C, Schleimer RP, Lambrecht BN, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020;6(1):86.
doi: 10.1038/s41572-020-00218-1 pubmed: 33122665
Deutsch PG, Lord S, Salamat S, Jolly K. The management of chronic rhinosinusitis in primary care: an evidence-based guide. Br J Gen Pract. 2019;69(678):44–5.
doi: 10.3399/bjgp19X700637 pubmed: 30591615 pmcid: 6301374
Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;14:127–34.
Claeys N, Teeling MT, Legrand P, Poppe M, Verschueren P, De Prins L, et al. Patients unmet needs in chronic rhinosinusitis with nasal polyps care: a Patient Advisory Board Statement of EUFOREA. Front Allergy. 2021;2:761388.
Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes - a means to understand. Curr Med Res Opin. 2008;24(11):3063–72.
Benson V, Chan R, Sousa A, Small M, Scott M, Milligan G, et al. Nasal polyp symptoms: how well do physicians know their patients? J Allergy Clin Immunol. 2020;145(2):AB148.
Hwee J, Smith S, Small M, Lee L, Yang S. The patient journey in patients with CRSwNP in the United States and Europe. American Thoracic Society; May 17, 2022; San Francisco, CA. Am J Respir Crit Care Med 2022. p. A3992–A.
Vennik J, Eyles C, Thomas M, Hopkins C, Little P, Blackshaw H, et al. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care. BMJ Open. 2019;9(4):e022644.
doi: 10.1136/bmjopen-2018-022644 pubmed: 31015263 pmcid: 6501991
DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2017;127(3):550–5.
doi: 10.1002/lary.26391 pubmed: 27859303

Auteurs

Jeremiah Hwee (J)

Value Evidence and Outcomes, GSK, Mississauga, ON, Canada. jeremiah.x.hwee@gsk.com.

Lauren Lee (L)

Adelphi Real World, Bollington, Cheshire, UK.

Mark Small (M)

Adelphi Real World, Bollington, Cheshire, UK.

Steven G Smith (SG)

Clinical Sciences, GSK, Durham, NC, USA.

Victoria S Benson (VS)

Epidemiology, Value Evidence and Outcomes, GSK, Brentford, Middlesex, UK.

Shiyuan Zhang (S)

Value Evidence and Outcomes, GSK, Collegeville, PA, USA.

Classifications MeSH